US Approves Sanofi, Regeneron Arthritis Drug
US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the chronic inflammatory condition, rheumatoid arthritis. The Food and Drug Administration authorisation had been delayed over “deficiencies” found by the regulatory agency during an inspection of the Sanofi manufacturing site in … Read more